Allison Baxley Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

6/2015

Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allison Baxley Research Topics

Disease

1	Injection Site Reaction 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Residual Neoplasm 06/2015
1	Anus Neoplasms (Anal Cancer) 06/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2015
1	Neoplasms (Cancer) 06/2015
1	Infections 11/2011
1	Autoimmune Diseases (Autoimmune Disease) 11/2011

Drug/Important Bio-Agent (IBA)

1	fosaprepitant FDA Link 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2015
1	Fluorouracil (Carac)FDA LinkGeneric 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	Ifosfamide FDA LinkGeneric 06/2015
1	Cetuximab (Erbitux)FDA Link 06/2015
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2015
1	Cisplatin (Platino)FDA LinkGeneric 06/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2011

Therapy/Procedure

2	Therapeutics 06/2015 - 11/2011
1	Combined Modality Therapy 06/2015
1	Drug Therapy (Chemotherapy) 06/2015